Patents by Inventor Jin Pei

Jin Pei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC ANTIBODY AND USE THEREOF
    Publication number: 20240067728
    Abstract: The present invention provides a bispecific antibody and use thereof, and the bispecific antibody or an antigen-binding fragment of the present invention can bind to two or more antigens or two or more epitopes of a same antigen. The antibody or the antigen-binding fragment of the present invention can be used to treat a variety of diseases, such as inflammatory diseases, autoimmune diseases, cancers or spinal cord injury, and can also be used for diagnosis and prognosis of related diseases.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 29, 2024
    Inventors: Yifan CHEN, Qiulian LIANG, Shujun PEI, Jin-Chen YU, Shengfeng LI
  • Ophthalmic hGM-CSF preparation
    Patent number: 7858582
    Abstract: The present invention provides an external preparation and the method for produce the same, in which said external preparation comprises recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carriers. The present invention also relates to application and usage method in preparing medicaments for treatment of various lesions and ulcers, especially corneal lesions and corneal ulcers.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: December 28, 2010
    Assignee: Genescience Pharmaceuticals Co., Ltd.
    Inventors: Lei Jin, Jin Pei, Gang Meng, Junmei Hu
  • EXTERNAL PREPARATION, METHOD OF PRODUCING THE SAME AND USAGE FOR THE SAME
    Publication number: 20090156482
    Abstract: The present invention provides an external preparation and the method for produce the same, in which said external preparation comprises recombinant human growth hormone or recombinant human granulocyte macrophage-stimulating factor and pharmaceutical acceptable carriers. The present invention also relates to application and usage method in preparing medicaments for treatment of various lesions and ulcer, especially corneal lesion and corneal ulcer.
    Type: Application
    Filed: June 23, 2006
    Publication date: June 18, 2009
    Applicant: GENESCIENCE PHARMACEUTICALS CO., LTD.
    Inventors: Lei Jin, Jin Pei, Gang Meng, Junmei Hu
  • Chemosensitizing with liposomes containing oligonucleotides
    Patent number: 7262173
    Abstract: The invention relates to the use of oligonucleotide containing cationic liposomal formulations to enhance the efficacy of chemotherapy and/or radiotherapy, particularly as a means to sensitize cancerous tumor tissues to the efficiencies of chemotherapy. This is particularly advantageous in the context of treating raf expressing tumors such as breast, lung, pancreatic and prostate tumors.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: August 28, 2007
    Assignees: Georgetown University, NeoPharm, Inc.
    Inventors: Usha Kasid, Prafulla Gokhale, Jin Pei, Rajshree Mewani, Imran Ahmad, Anatoly Dritschilo, Aquilur Rahman
  • Chemosensitizing with liposomes containing oligonucleotides
    Publication number: 20030215489
    Abstract: The invention relates to the use of oliognucleotide containing cationic liposomal formulations to enhance the efficacy of chemotherapy and/or radiotherapy, particularly as a means to chemosensitize cancer are tumor tissues to the efficiencies of chemotherapy. This is particularly advantageous in the context of treatment of ras expressing tumors such as breast, lung, pancreatic and prostate cancer.
    Type: Application
    Filed: February 15, 2002
    Publication date: November 20, 2003
    Applicant: Georgetown University
    Inventors: Usha Kasid, Prafulla Gokhale, Jin Pei, Rajshree Mewani, Imran Ahmad, Anatoly Dritschilo, Aquilur Rahman